49 results
P
adult patients undergoing minimally invasive cardiac surgery
I/C
Del Nido cardioplegia, Custoidol solution, blood cardioplegia, crystalloid cardioplegia, Del Nido cardioplegia vs Blood, Custoidol solution vs Blood
O
in-hospital or 30-day mortality
P
adult patients (≥18 years old)
I/C
del Nido cardioplegia, other cardioplegias
O
postoperative stroke and/or transient ischemic attack rate, aortic cross-clamp time, need for defibrillation, postoperative acute kidney injury, mortality
P
Dr. Somovilla del Saz
I/C
vaccination against COVID-19, self-controlled case series studies
O
all-cause and cardiac-related mortality
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
mujeres postmenopáusicas
I/C
uso de estrógenos
O
infección del tracto urinario sintomática
P
hypertensive COVID-19 patients
I/C
chronic use of RAAS inhibitors, ACEIs and ARBs among hypertensive patients
O
all-cause mortality
P
54,471 participants
I/C
hand-washing promotion, no intervention
O
diarrhea episodes
P
patients with risk factors for surgical-site complications
I/C
prophylactic use of a specific single-use negative-pressure wound therapy (sNPWT) device, conventional dressings
O
surgical-site infection (SSI), wound dehiscence, seroma, necrosis, mean length of hospital stay
P
people being investigated for tuberculosis
I/C
Xpert MTB/RIF, smear microscopy
O
mortality, proportion of participants starting tuberculosis treatment who had a successful treatment outcome, proportion of participants who were treated for tuberculosis, proportion of participants with bacteriological confirmation who were lost to follow-up pre-treatment, proportion of treated participants who had bacteriological confirmation
